Instead, we noticed that in IGR37 metastatic melanoma cells overexpressing LATS1, BACE2 inhibition, and rPMEL fibril administration have no effects on YAP activation (Fig. 5I, J). The gene discussed is BACE2; the disease is metastatic melanoma.